{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T05:35:32Z","timestamp":1769232932169,"version":"3.49.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bipolar Disorder (BD) is a complex mental disease characterized by recurrent episodes of mania and depression. Lithium (Li) represents the mainstay of BD pharmacotherapy, despite the narrow therapeutic index and the high variability in treatment response. However, although several studies have been conducted, the molecular mechanisms underlying Li therapeutic effects remain unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In order to identify molecular signatures and biological pathways associated with Li treatment response, we conducted transcriptome and miRNome microarray analyses on lymphoblastoid cell lines (LCLs) from 20 patients diagnosed with BD classified as Li responders (<jats:italic>n<\/jats:italic>\u2009=\u200911) or non-responders (<jats:italic>n<\/jats:italic>\u2009=\u20099).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found 335 mRNAs and 77 microRNAs (miRNAs) significantly modulated in BD responders versus non-responders. Interestingly, pathway and network analyses on these differentially expressed molecules suggested a modulatory effect of Li on several immune-related functions. Indeed, among the functional molecular nodes, we found NF-\u03baB and TNF. Moreover, networks related to these molecules resulted overall inhibited in BD responder patients, suggesting anti-inflammatory properties of Li.<\/jats:p>\n                <jats:p>From the integrative analysis between transcriptomics and miRNomics data carried out using miRComb R package on the same samples from patients diagnosed with BD, we found 97 significantly and negatively correlated mRNA-miRNA pairs, mainly involved in inflammatory\/immune response.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results highlight that Li exerts modulatory effects on immune-related functions and that epigenetic mechanisms, especially miRNAs, can influence the modulation of different genes and pathways involved in Li response. Moreover, our data suggest the potentiality to integrate data coming from different high-throughput approaches as a tool to prioritize genes and pathways.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-022-04286-3","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T23:04:23Z","timestamp":1666911863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Transcriptomics and miRNomics data integration in lymphoblastoid cells highlights the key role of immune-related functions in lithium treatment response in Bipolar disorder"],"prefix":"10.1186","volume":"22","author":[{"given":"Nadia","family":"Cattane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindie","family":"Courtin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Mombelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Maj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Etain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Bellivier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Marie-Claire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"issue":"2","key":"4286_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S2215-0366(15)00505-2","volume":"3","author":"D Vigo","year":"2016","unstructured":"Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. Lancet Psychiatry. 2016;3(2):171\u20138. https:\/\/doi.org\/10.1016\/S2215-0366(15)00505-2.","journal-title":"Lancet Psychiatry"},{"key":"4286_CR2","doi-asserted-by":"publisher","unstructured":"Vieta E, Berk M, Schulze TG, Carvalho AF, Suppes T, Calabrese JR, et al. Bipolar disorders. Nature Reviews Disease Primers. 2018;4:18008. https:\/\/doi.org\/10.1038\/nrdp.2018.8.","DOI":"10.1038\/nrdp.2018.8"},{"issue":"10027","key":"4286_CR3","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","volume":"387","author":"I Grande","year":"2016","unstructured":"Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet. 2016;387(10027):1561\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(15)00241-X.","journal-title":"Lancet"},{"key":"4286_CR4","doi-asserted-by":"publisher","unstructured":"Won E, Kim YK. An Oldie but Goodie: Lithium in the treatment of Bipolar disorder through neuroprotective and neurotrophic mechanisms. Int J Mol Sci. 2017;18(12). https:\/\/doi.org\/10.3390\/ijms18122679.","DOI":"10.3390\/ijms18122679"},{"issue":"9878","key":"4286_CR5","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","volume":"381","author":"JR Geddes","year":"2013","unstructured":"Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. Lancet. 2013;381(9878):1672\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(13)60857-0.","journal-title":"Lancet"},{"issue":"9817","key":"4286_CR6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(11)61516-X","volume":"379","author":"RF McKnight","year":"2012","unstructured":"McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379(9817):721\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(11)61516-X.","journal-title":"Lancet"},{"issue":"10023","key":"4286_CR7","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(16)00143-4","volume":"387","author":"L Hou","year":"2016","unstructured":"Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, et al. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet. 2016;387(10023):1085\u201393. https:\/\/doi.org\/10.1016\/S0140-6736(16)00143-4.","journal-title":"Lancet"},{"issue":"5","key":"4286_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1055\/a-0650-4820","volume":"51","author":"F Bellivier","year":"2018","unstructured":"Bellivier F, Marie-Claire C. Molecular signatures of Lithium treatment: current knowledge. Pharmacopsychiatry. 2018;51(5):212\u20139. https:\/\/doi.org\/10.1055\/a-0650-4820.","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"4286_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2217\/pgs-2017-0111","volume":"19","author":"C Pisanu","year":"2018","unstructured":"Pisanu C, Katsila T, Patrinos GP, Squassina A. Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment. Pharmacogenomics. 2018;19(2):129\u201343. https:\/\/doi.org\/10.2217\/pgs-2017-0111.","journal-title":"Pharmacogenomics"},{"issue":"6","key":"4286_CR10","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.pnpbp.2005.03.021","volume":"29","author":"M Alda","year":"2005","unstructured":"Alda M, Grof P, Rouleau GA, Turecki G, Young LT. Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2005;29(6):1038\u201345. https:\/\/doi.org\/10.1016\/j.pnpbp.2005.03.021.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"8","key":"4286_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/gm79","volume":"1","author":"C Cruceanu","year":"2009","unstructured":"Cruceanu C, Alda M, Turecki G. Lithium: a key to the genetics of bipolar disorder. Genome medicine. 2009;1(8):79. https:\/\/doi.org\/10.1186\/gm79.","journal-title":"Genome medicine"},{"issue":"10","key":"4286_CR12","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1139\/gen-2013-0081","volume":"56","author":"C Cruceanu","year":"2013","unstructured":"Cruceanu C, Ambalavanan A, Spiegelman D, Gauthier J, Lafreniere RG, Dion PA, et al. Family-based exome-sequencing approach identifies rare susceptibility variants for lithium-responsive bipolar disorder. Genome. 2013;56(10):634\u201340. https:\/\/doi.org\/10.1139\/gen-2013-0081.","journal-title":"Genome"},{"key":"4286_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2741\/e696","volume":"6","author":"PA Geoffroy","year":"2014","unstructured":"Geoffroy PA, Bellivier F, Leboyer M, Etain B. Can the response to mood stabilizers be predicted in bipolar disorder? Front Biosci. 2014;6:120\u201338. https:\/\/doi.org\/10.2741\/e696.","journal-title":"Front Biosci"},{"issue":"3","key":"4286_CR14","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s13311-017-0554-7","volume":"14","author":"BS Pickard","year":"2017","unstructured":"Pickard BS. Genomics of Lithium action and response. Neurotherapeutics. 2017;14(3):582\u20137. https:\/\/doi.org\/10.1007\/s13311-017-0554-7.","journal-title":"Neurotherapeutics"},{"issue":"6","key":"4286_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.euroneuro.2017.02.001","volume":"27","author":"M Budde","year":"2017","unstructured":"Budde M, Degner D, Brockmoller J, Schulze TG. Pharmacogenomic aspects of bipolar disorder: an update. Eur Neuropsychopharmacol. 2017;27(6):599\u2013609. https:\/\/doi.org\/10.1016\/j.euroneuro.2017.02.001.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"4286_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s40291-018-0335-y","volume":"22","author":"C Pisanu","year":"2018","unstructured":"Pisanu C, Heilbronner U, Squassina A. The role of pharmacogenomics in Bipolar disorder: moving towards precision medicine. Mol Diagn Ther. 2018;22(4):409\u201320. https:\/\/doi.org\/10.1007\/s40291-018-0335-y.","journal-title":"Mol Diagn Ther"},{"issue":"7","key":"4286_CR17","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/aur.1789","volume":"10","author":"Y Hu","year":"2017","unstructured":"Hu Y, Ehli EA, Boomsma DI. MicroRNAs as biomarkers for psychiatric disorders with a focus on autism spectrum disorder: current progress in genetic association studies, expression profiling, and translational research. Autism Res. 2017;10(7):1184\u2013203. https:\/\/doi.org\/10.1002\/aur.1789.","journal-title":"Autism Res"},{"issue":"13","key":"4286_CR18","doi-asserted-by":"publisher","first-page":"5682","DOI":"10.1093\/nar\/gkr155","volume":"39","author":"ST Younger","year":"2011","unstructured":"Younger ST, Corey DR. Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters. Nucleic Acids Res. 2011;39(13):5682\u201391. https:\/\/doi.org\/10.1093\/nar\/gkr155.","journal-title":"Nucleic Acids Res"},{"key":"4286_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.pnpbp.2015.02.003","volume":"64","author":"Y Dwivedi","year":"2016","unstructured":"Dwivedi Y. Pathogenetic and therapeutic applications of microRNAs in major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2016;64:341\u20138. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.02.003.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"6","key":"4286_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/14737159.2018.1470927","volume":"18","author":"C Mora","year":"2018","unstructured":"Mora C, Zonca V, Riva MA, Cattaneo A. Blood biomarkers and treatment response in major depression. Expert Rev Mol Diagn. 2018;18(6):513\u201329. https:\/\/doi.org\/10.1080\/14737159.2018.1470927.","journal-title":"Expert Rev Mol Diagn"},{"issue":"13","key":"4286_CR21","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1242\/dev.144337","volume":"144","author":"M Rajman","year":"2017","unstructured":"Rajman M, Schratt G. MicroRNAs in neural development: from master regulators to fine-tuners. Development. 2017;144(13):2310\u201322. https:\/\/doi.org\/10.1242\/dev.144337.","journal-title":"Development"},{"key":"4286_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.lfs.2017.08.033","volume":"188","author":"CW Wei","year":"2017","unstructured":"Wei CW, Luo T, Zou SS, Wu AS. Research progress on the roles of microRNAs in governing synaptic plasticity, learning and memory. Life Sci. 2017;188:118\u201322. https:\/\/doi.org\/10.1016\/j.lfs.2017.08.033.","journal-title":"Life Sci"},{"key":"4286_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-3-319-22671-2_6","volume":"888","author":"L Qiu","year":"2015","unstructured":"Qiu L, Tan EK, Zeng L. microRNAs and neurodegenerative diseases. Adv Exp Med Biol. 2015;888:85\u2013105. https:\/\/doi.org\/10.1007\/978-3-319-22671-2_6.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"4286_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2217\/bmm-2016-0242","volume":"11","author":"V Viswambharan","year":"2017","unstructured":"Viswambharan V, Thanseem I, Vasu MM, Poovathinal SA, Anitha A. miRNAs as biomarkers of neurodegenerative disorders. Biomark Med. 2017;11(2):151\u201367. https:\/\/doi.org\/10.2217\/bmm-2016-0242.","journal-title":"Biomark Med"},{"key":"4286_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pharmthera.2016.07.006","volume":"167","author":"A Luoni","year":"2016","unstructured":"Luoni A, Riva MA. MicroRNAs and psychiatric disorders: from aetiology to treatment. Pharmacol Ther. 2016;167:13\u201327. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.07.006.","journal-title":"Pharmacol Ther"},{"key":"4286_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neulet.2016.06.045","volume":"669","author":"C Pisanu","year":"2018","unstructured":"Pisanu C, Papadima EM, Del Zompo M, Squassina A. Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics. Neurosci Lett. 2018;669:24\u201331. https:\/\/doi.org\/10.1016\/j.neulet.2016.06.045.","journal-title":"Neurosci Lett"},{"key":"4286_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jad.2017.09.025","volume":"233","author":"GR Fries","year":"2018","unstructured":"Fries GR, Carvalho AF, Quevedo J. The miRNome of bipolar disorder. J Affect Disord. 2018;233:110\u20136. https:\/\/doi.org\/10.1016\/j.jad.2017.09.025.","journal-title":"J Affect Disord"},{"issue":"9","key":"4286_CR28","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/jnr.22000","volume":"87","author":"L Sie","year":"2009","unstructured":"Sie L, Loong S, Tan EK. Utility of lymphoblastoid cell lines. J Neurosci Res. 2009;87(9):1953\u20139. https:\/\/doi.org\/10.1002\/jnr.22000.","journal-title":"J Neurosci Res"},{"issue":"5","key":"4286_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/tpj.2016.50","volume":"16","author":"MS Breen","year":"2016","unstructured":"Breen MS, White CH, Shekhtman T, Lin K, Looney D, Woelk CH, et al. Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines. Pharmacogenomics J. 2016;16(5):446\u201353. https:\/\/doi.org\/10.1038\/tpj.2016.50.","journal-title":"Pharmacogenomics J"},{"key":"4286_CR30","doi-asserted-by":"publisher","first-page":"e504","DOI":"10.1038\/tp.2014.139","volume":"5","author":"JG Hunsberger","year":"2015","unstructured":"Hunsberger JG, Chibane FL, Elkahloun AG, Henderson R, Singh R, Lawson J, et al. Novel integrative genomic tool for interrogating lithium response in bipolar disorder. Transl Psychiatry. 2015;5:e504. https:\/\/doi.org\/10.1038\/tp.2014.139.","journal-title":"Transl Psychiatry"},{"issue":"8","key":"4286_CR31","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/15622975.2017.1282174","volume":"19","author":"PA Geoffroy","year":"2018","unstructured":"Geoffroy PA, Curis E, Courtin C, Moreira J, Morvillers T, Etain B, et al. Lithium response in bipolar disorders and core clock genes expression. World J Biol Psychiatry. 2018;19(8):619\u201332. https:\/\/doi.org\/10.1080\/15622975.2017.1282174.","journal-title":"World J Biol Psychiatry"},{"issue":"2","key":"4286_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00702-009-0340-8","volume":"117","author":"H Sugawara","year":"2010","unstructured":"Sugawara H, Iwamoto K, Bundo M, Ishiwata M, Ueda J, Kakiuchi C, et al. Effect of mood stabilizers on gene expression in lymphoblastoid cells. J Neural Transm. 2010;117(2):155\u201364. https:\/\/doi.org\/10.1007\/s00702-009-0340-8.","journal-title":"J Neural Transm"},{"issue":"11","key":"4286_CR33","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.euroneuro.2017.09.003","volume":"27","author":"GR Fries","year":"2017","unstructured":"Fries GR, Colpo GD, Monroy-Jaramillo N, Zhao J, Zhao Z, Arnold JG, et al. Distinct lithium-induced gene expression effects in lymphoblastoid cell lines from patients with bipolar disorder. Eur Neuropsychopharmacol. 2017;27(11):1110\u20139. https:\/\/doi.org\/10.1016\/j.euroneuro.2017.09.003.","journal-title":"Eur Neuropsychopharmacol"},{"key":"4286_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jad.2015.05.037","volume":"184","author":"B Viswanath","year":"2015","unstructured":"Viswanath B, Jose SP, Squassina A, Thirthalli J, Purushottam M, Mukherjee O, et al. Cellular models to study bipolar disorder: a systematic review. J Affect Disord. 2015;184:36\u201350. https:\/\/doi.org\/10.1016\/j.jad.2015.05.037.","journal-title":"J Affect Disord"},{"issue":"3","key":"4286_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.31887\/DCNS.2016.18.3\/dgurwitz","volume":"18","author":"D Gurwitz","year":"2016","unstructured":"Gurwitz D. Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders. Dialogues Clin Neurosci. 2016;18(3):267\u201376.","journal-title":"Dialogues Clin Neurosci"},{"key":"4286_CR36","doi-asserted-by":"publisher","unstructured":"Wang L, Laing J, Yan B, Zhou H, Ke L, Wang C, et al. Epstein-Barr virus Episome physically interacts with active regions of the host genome in Lymphoblastoid cells. J Virol. 2020;94(24). https:\/\/doi.org\/10.1128\/JVI.01390-20.","DOI":"10.1128\/JVI.01390-20"},{"issue":"11","key":"4286_CR37","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1111\/ajt.13375","volume":"15","author":"A Harris-Arnold","year":"2015","unstructured":"Harris-Arnold A, Arnold CP, Schaffert S, Hatton O, Krams SM, Esquivel CO, et al. Epstein-Barr virus modulates host cell microRNA-194 to promote IL-10 production and B lymphoma cell survival. Am J Transplant. 2015;15(11):2814\u201324. https:\/\/doi.org\/10.1111\/ajt.13375.","journal-title":"Am J Transplant"},{"issue":"12","key":"4286_CR38","doi-asserted-by":"publisher","first-page":"6889","DOI":"10.1128\/JVI.07056-11","volume":"86","author":"E Forte","year":"2012","unstructured":"Forte E, Salinas RE, Chang C, Zhou T, Linnstaedt SD, Gottwein E, et al. The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells. J Virol. 2012;86(12):6889\u201398. https:\/\/doi.org\/10.1128\/JVI.07056-11.","journal-title":"J Virol"},{"issue":"1","key":"4286_CR39","doi-asserted-by":"publisher","first-page":"e1002484","DOI":"10.1371\/journal.ppat.1002484","volume":"8","author":"RL Skalsky","year":"2012","unstructured":"Skalsky RL, Corcoran DL, Gottwein E, Frank CL, Kang D, Hafner M, et al. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog. 2012;8(1):e1002484. https:\/\/doi.org\/10.1371\/journal.ppat.1002484.","journal-title":"PLoS Pathog"},{"issue":"1","key":"4286_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1365-2184.2010.00717.x","volume":"44","author":"JE Lee","year":"2011","unstructured":"Lee JE, Hong EJ, Nam HY, Kim JW, Han BG, Jeon JP. MicroRNA signatures associated with immortalization of EBV-transformed lymphoblastoid cell lines and their clinical traits. Cell Prolif. 2011;44(1):59\u201366. https:\/\/doi.org\/10.1111\/j.1365-2184.2010.00717.x.","journal-title":"Cell Prolif"},{"issue":"22","key":"4286_CR41","doi-asserted-by":"publisher","first-page":"11670","DOI":"10.1128\/JVI.01248-10","volume":"84","author":"SD Linnstaedt","year":"2010","unstructured":"Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J Virol. 2010;84(22):11670\u20138. https:\/\/doi.org\/10.1128\/JVI.01248-10.","journal-title":"J Virol"},{"key":"4286_CR42","doi-asserted-by":"publisher","first-page":"629780","DOI":"10.3389\/fonc.2021.629780","volume":"11","author":"MML Leong","year":"2021","unstructured":"Leong MML, Lung ML. The impact of Epstein-Barr virus infection on epigenetic regulation of host cell gene expression in epithelial and lymphocytic malignancies. Front Oncol. 2021;11:629780. https:\/\/doi.org\/10.3389\/fonc.2021.629780.","journal-title":"Front Oncol"},{"issue":"10","key":"4286_CR43","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s40263-016-0380-1","volume":"30","author":"GS Malhi","year":"2016","unstructured":"Malhi GS, Outhred T. Therapeutic mechanisms of Lithium in Bipolar disorder: recent advances and current understanding. CNS drugs. 2016;30(10):931\u201349. https:\/\/doi.org\/10.1007\/s40263-016-0380-1.","journal-title":"CNS drugs"},{"issue":"6","key":"4286_CR44","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/mp.2015.4","volume":"20","author":"M Alda","year":"2015","unstructured":"Alda M. Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics. Mol Psychiatry. 2015;20(6):661\u201370. https:\/\/doi.org\/10.1038\/mp.2015.4.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"4286_CR45","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/eip.12775","volume":"13","author":"OD Robertson","year":"2019","unstructured":"Robertson OD, Coronado NG, Sethi R, Berk M, Dodd S. Putative neuroprotective pharmacotherapies to target the staged progression of mental illness. Early Interv Psychiatry. 2019;13(5):1032\u201349. https:\/\/doi.org\/10.1111\/eip.12775.","journal-title":"Early Interv Psychiatry"},{"issue":"6","key":"4286_CR46","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00232-017-9998-2","volume":"250","author":"E Jakobsson","year":"2017","unstructured":"Jakobsson E, Arguello-Miranda O, Chiu SW, Fazal Z, Kruczek J, Nunez-Corrales S, et al. Towards a unified understanding of Lithium action in basic biology and its significance for applied biology. J Membr Biol. 2017;250(6):587\u2013604. https:\/\/doi.org\/10.1007\/s00232-017-9998-2.","journal-title":"J Membr Biol"},{"issue":"3","key":"4286_CR47","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s12031-015-0523-8","volume":"56","author":"E Milanesi","year":"2015","unstructured":"Milanesi E, Hadar A, Maffioletti E, Werner H, Shomron N, Gennarelli M, et al. Insulin-like growth factor 1 differentially affects Lithium sensitivity of Lymphoblastoid cell lines from Lithium responder and non-responder Bipolar disorder patients. J Mol Neurosci. 2015;56(3):681\u20137. https:\/\/doi.org\/10.1007\/s12031-015-0523-8.","journal-title":"J Mol Neurosci"},{"issue":"7","key":"4286_CR48","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/ajmg.b.32663","volume":"177","author":"C Pisanu","year":"2018","unstructured":"Pisanu C, Congiu D, Costa M, Chillotti C, Ardau R, Severino G, et al. Convergent analysis of genome-wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2018;177(7):658\u201364. https:\/\/doi.org\/10.1002\/ajmg.b.32663.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"4286_CR49","doi-asserted-by":"publisher","unstructured":"Vila-Casadesus M, Gironella M, Lozano JJ. MiRComb: An R package to analyse miRNA-mRNA interactions Examples across Five Digestive Cancers. PloS one 2016;11(3):e0151127. doi:https:\/\/doi.org\/10.1371\/journal.pone.0151127.","DOI":"10.1371\/journal.pone.0151127"},{"issue":"10","key":"4286_CR50","doi-asserted-by":"publisher","first-page":"942","DOI":"10.4088\/jcp.v63n1013","volume":"63","author":"P Grof","year":"2002","unstructured":"Grof P, Duffy A, Cavazzoni P, Grof E, Garnham J, MacDougall M, et al. Is response to prophylactic lithium a familial trait? The Journal of clinical psychiatry. 2002;63(10):942\u20137. https:\/\/doi.org\/10.4088\/jcp.v63n1013.","journal-title":"The Journal of clinical psychiatry"},{"issue":"4","key":"4286_CR51","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/BF00279094","volume":"73","author":"H Neitzel","year":"1986","unstructured":"Neitzel H. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet. 1986;73(4):320\u20136. https:\/\/doi.org\/10.1007\/BF00279094.","journal-title":"Hum Genet"},{"issue":"Web Server issu","key":"4286_CR52","doi-asserted-by":"publisher","first-page":"W498","DOI":"10.1093\/nar\/gks494","volume":"40","author":"IS Vlachos","year":"2012","unstructured":"Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, Maragkakis M, et al. DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic acids Res. 2012;40(Web Server issue):W498\u2013504. https:\/\/doi.org\/10.1093\/nar\/gks494.","journal-title":"Nucleic acids Res"},{"issue":"6","key":"4286_CR53","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/bioinformatics\/bts043","volume":"28","author":"M Reczko","year":"2012","unstructured":"Reczko M, Maragkakis M, Alexiou P, Grosse I, Hatzigeorgiou AG. Functional microRNA targets in protein coding sequences. Bioinformatics. 2012;28(6):771\u20136. https:\/\/doi.org\/10.1093\/bioinformatics\/bts043.","journal-title":"Bioinformatics"},{"issue":"6","key":"4286_CR54","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/15622975.2017.1372629","volume":"20","author":"E Milanesi","year":"2019","unstructured":"Milanesi E, Voinsky I, Hadar A, Srouji A, Maj C, Shekhtman T, et al. RNA sequencing of bipolar disorder lymphoblastoid cell lines implicates the neurotrophic factor HRP-3 in lithium's clinical efficacy. World J Biol Psychiatry. 2019;20(6):449\u201361. https:\/\/doi.org\/10.1080\/15622975.2017.1372629.","journal-title":"World J Biol Psychiatry"},{"issue":"6","key":"4286_CR55","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/15622975.2017.1396357","volume":"20","author":"S Kittel-Schneider","year":"2019","unstructured":"Kittel-Schneider S, Hilscher M, Scholz CJ, Weber H, Grunewald L, Schwarz R, et al. Lithium-induced gene expression alterations in two peripheral cell models of bipolar disorder. World J Biol Psychiatry. 2019;20(6):462\u201375. https:\/\/doi.org\/10.1080\/15622975.2017.1396357.","journal-title":"World J Biol Psychiatry"},{"issue":"2","key":"4286_CR56","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/hup.2381","volume":"29","author":"S Watanabe","year":"2014","unstructured":"Watanabe S, Iga J, Nishi A, Numata S, Kinoshita M, Kikuchi K, et al. Microarray analysis of global gene expression in leukocytes following lithium treatment. Human Psychopharmacol. 2014;29(2):190\u20138. https:\/\/doi.org\/10.1002\/hup.2381.","journal-title":"Human Psychopharmacol"},{"key":"4286_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2013.04.004","volume":"73","author":"A Squassina","year":"2013","unstructured":"Squassina A, Costa M, Congiu D, Manchia M, Angius A, Deiana V, et al. Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients. Pharmacol Res. 2013;73:1\u20137. https:\/\/doi.org\/10.1016\/j.phrs.2013.04.004.","journal-title":"Pharmacol Res"},{"issue":"4","key":"4286_CR58","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nrg.2016.18","volume":"17","author":"R Cloney","year":"2016","unstructured":"Cloney R. Complex traits: integrating gene variation and expression to understand complex traits. Nat Rev Genet. 2016;17(4):194. https:\/\/doi.org\/10.1038\/nrg.2016.18.","journal-title":"Nat Rev Genet"},{"issue":"7","key":"4286_CR59","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.cell.2018.05.046","volume":"173","author":"D Bipolar","year":"2018","unstructured":"Bipolar D. Schizophrenia working Group of the Psychiatric Genomics Consortium. Electronic address drve, Bipolar D, schizophrenia working Group of the Psychiatric Genomics C. genomic dissection of Bipolar disorder and schizophrenia, including 28 subphenotypes. Cell. 2018;173(7):1705\u201315 e16. https:\/\/doi.org\/10.1016\/j.cell.2018.05.046.","journal-title":"Cell"},{"issue":"7","key":"4286_CR60","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1017\/S1461145709000029","volume":"12","author":"H Chen","year":"2009","unstructured":"Chen H, Wang N, Burmeister M, McInnis MG. MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment. Int J Neuropsychopharmacol. 2009;12(7):975\u201381. https:\/\/doi.org\/10.1017\/S1461145709000029.","journal-title":"Int J Neuropsychopharmacol"},{"key":"4286_CR61","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neuroscience.2022.03.020","volume":"492","author":"M Garcia-Juarez","year":"2022","unstructured":"Garcia-Juarez M, Camacho-Morales A. Defining the role of anti- and pro-inflammatory outcomes of Interleukin-6 in mental health. Neuroscience. 2022;492:32\u201346. https:\/\/doi.org\/10.1016\/j.neuroscience.2022.03.020.","journal-title":"Neuroscience"},{"issue":"6","key":"4286_CR62","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1021\/cn500038f","volume":"5","author":"A Nassar","year":"2014","unstructured":"Nassar A, Azab AN. Effects of lithium on inflammation. ACS Chem Neurosci. 2014;5(6):451\u20138. https:\/\/doi.org\/10.1021\/cn500038f.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"4286_CR63","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jamapsychiatry.2017.3433","volume":"75","author":"AT Amare","year":"2018","unstructured":"International Consortium on Lithium G, Amare AT, Schubert KO, Hou L, Clark SR, Papiol S, et al. Association of Polygenic Score for schizophrenia and HLA antigen and inflammation genes with response to Lithium in Bipolar affective disorder: a genome-wide association study. JAMA Psychiatry. 2018;75(1):65\u201374. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.3433.","journal-title":"JAMA Psychiatry"},{"key":"4286_CR64","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","volume":"148","author":"E Beurel","year":"2015","unstructured":"Beurel E, Grieco SF, Jope RS. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther. 2015;148:114\u201331. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.11.016.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"4286_CR65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1385\/ct:6:2:111","volume":"6","author":"AR Brasier","year":"2006","unstructured":"Brasier AR. The NF-kappaB regulatory network. Cardiovasc Toxicol. 2006;6(2):111\u201330. https:\/\/doi.org\/10.1385\/ct:6:2:111.","journal-title":"Cardiovasc Toxicol"},{"issue":"1\u20133","key":"4286_CR66","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jad.2012.04.044","volume":"143","author":"S Guloksuz","year":"2012","unstructured":"Guloksuz S, Altinbas K, Aktas Cetin E, Kenis G, Bilgic Gazioglu S, Deniz G, et al. Evidence for an association between tumor necrosis factor-alpha levels and lithium response. J Affect Disord. 2012;143(1\u20133):148\u201352. https:\/\/doi.org\/10.1016\/j.jad.2012.04.044.","journal-title":"J Affect Disord"},{"issue":"12","key":"4286_CR67","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/s41398-017-0028-z","volume":"7","author":"X Chen","year":"2017","unstructured":"Chen X, Ku L, Mei R, Liu G, Xu C, Wen Z, et al. Novel schizophrenia risk factor pathways regulate FEZ1 to advance oligodendroglia development. Transl Psychiatry. 2017;7(12):1293. https:\/\/doi.org\/10.1038\/s41398-017-0028-z.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"4286_CR68","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1515\/bjmg-2015-0003","volume":"18","author":"TI Vachev","year":"2015","unstructured":"Vachev TI, Stoyanova VK, Ivanov HY, Minkov IN, Popov NT. Investigation of fasciculation and elongation protein zeta-1 (FEZ1) in peripheral blood reveals differences in gene expression in patients with schizophrenia. Balkan J Med Genet. 2015;18(1):31\u20138. https:\/\/doi.org\/10.1515\/bjmg-2015-0003.","journal-title":"Balkan J Med Genet"},{"key":"4286_CR69","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1100\/tsw.2010.151","volume":"10","author":"AD Maturana","year":"2010","unstructured":"Maturana AD, Fujita T, Kuroda S. Functions of fasciculation and elongation protein zeta-1 (FEZ1) in the brain. ScientificWorldJournal. 2010;10:1646\u201354. https:\/\/doi.org\/10.1100\/tsw.2010.151.","journal-title":"ScientificWorldJournal"},{"issue":"1","key":"4286_CR70","doi-asserted-by":"publisher","first-page":"e48814","DOI":"10.1371\/journal.pone.0048814","volume":"8","author":"MG Banigan","year":"2013","unstructured":"Banigan MG, Kao PF, Kozubek JA, Winslow AR, Medina J, Costa J, et al. Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients. PLoS One. 2013;8(1):e48814. https:\/\/doi.org\/10.1371\/journal.pone.0048814.","journal-title":"PLoS One"},{"issue":"2","key":"4286_CR71","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/sj.mp.4001306","volume":"8","author":"RH Lenox","year":"2003","unstructured":"Lenox RH, Wang L. Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks. Mol Psychiatry. 2003;8(2):135\u201344. https:\/\/doi.org\/10.1038\/sj.mp.4001306.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"4286_CR72","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/mp.2014.176","volume":"20","author":"S Bavamian","year":"2015","unstructured":"Bavamian S, Mellios N, Lalonde J, Fass DM, Wang J, Sheridan SD, et al. Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder. Mol Psychiatry. 2015;20(5):573\u201384. https:\/\/doi.org\/10.1038\/mp.2014.176.","journal-title":"Mol Psychiatry"},{"key":"4286_CR73","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fncel.2015.00209","volume":"9","author":"B Alural","year":"2015","unstructured":"Alural B, Ozerdem A, Allmer J, Genc K, Genc S. Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells. Front Cell Neurosci. 2015;9:209. https:\/\/doi.org\/10.3389\/fncel.2015.00209.","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"4286_CR74","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1007\/s11033-021-06430-w","volume":"48","author":"KU Tufekci","year":"2021","unstructured":"Tufekci KU, Alural B, Tarakcioglu E, San T, Genc S. Lithium inhibits oxidative stress-induced neuronal senescence through miR-34a. Mol Biol Rep. 2021;48(5):4171\u201380. https:\/\/doi.org\/10.1007\/s11033-021-06430-w.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"4286_CR75","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1182\/blood-2008-09-179150","volume":"114","author":"ST Hashimi","year":"2009","unstructured":"Hashimi ST, Fulcher JA, Chang MH, Gov L, Wang S, Lee B. MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood. 2009;114(2):404\u201314. https:\/\/doi.org\/10.1182\/blood-2008-09-179150.","journal-title":"Blood"},{"issue":"197","key":"4286_CR76","doi-asserted-by":"publisher","first-page":"ra71","DOI":"10.1126\/scisignal.2001744","volume":"4","author":"NH Kim","year":"2011","unstructured":"Kim NH, Kim HS, Kim NG, Lee I, Choi HS, Li XY, et al. p53 and microRNA-34 are suppressors of canonical Wnt signaling. Sci Signal. 2011;4(197):ra71. https:\/\/doi.org\/10.1126\/scisignal.2001744.","journal-title":"Sci Signal"},{"issue":"Suppl 2","key":"4286_CR77","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1399-5618.2009.00714.x","volume":"11","author":"R Machado-Vieira","year":"2009","unstructured":"Machado-Vieira R, Manji HK, Zarate CA Jr. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord. 2009;11(Suppl 2):92\u2013109. https:\/\/doi.org\/10.1111\/j.1399-5618.2009.00714.x.","journal-title":"Bipolar Disord"},{"issue":"2","key":"4286_CR78","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40263-013-0039-0","volume":"27","author":"GS Malhi","year":"2013","unstructured":"Malhi GS, Tanious M, Das P, Coulston CM, Berk M. Potential mechanisms of action of lithium in bipolar disorder Current understanding. CNS drugs. 2013;27(2):135\u201353. https:\/\/doi.org\/10.1007\/s40263-013-0039-0.","journal-title":"CNS drugs"},{"issue":"6","key":"4286_CR79","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/npp.2008.131","volume":"34","author":"R Zhou","year":"2009","unstructured":"Zhou R, Yuan P, Wang Y, Hunsberger JG, Elkahloun A, Wei Y, et al. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology. 2009;34(6):1395\u2013405. https:\/\/doi.org\/10.1038\/npp.2008.131.","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"4286_CR80","first-page":"450","volume":"5","author":"JG Hunsberger","year":"2013","unstructured":"Hunsberger JG, Fessler EB, Chibane FL, Leng Y, Maric D, Elkahloun AG, et al. Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions. Am J Transl Res. 2013;5(4):450\u201364.","journal-title":"Am J Transl Res"},{"issue":"2","key":"4286_CR81","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000430867","volume":"1","author":"L Backlund","year":"2015","unstructured":"Backlund L, Wei YB, Martinsson L, Melas PA, Liu JJ, Mu N, et al. Mood stabilizers and the influence on global leukocyte DNA methylation in Bipolar disorder. Mol Neuropsychiatry. 2015;1(2):76\u201381. https:\/\/doi.org\/10.1159\/000430867.","journal-title":"Mol Neuropsychiatry"},{"issue":"4","key":"4286_CR82","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1017\/S1461145713001569","volume":"17","author":"AA Huzayyin","year":"2014","unstructured":"Huzayyin AA, Andreazza AC, Turecki G, Cruceanu C, Rouleau GA, Alda M, et al. Decreased global methylation in patients with bipolar disorder who respond to lithium. Int J Neuropsychopharmacol. 2014;17(4):561\u20139. https:\/\/doi.org\/10.1017\/S1461145713001569.","journal-title":"Int J Neuropsychopharmacol"},{"key":"4286_CR83","doi-asserted-by":"publisher","unstructured":"Pisanu C, Merkouri Papadima E, Melis C, Congiu D, Loizedda A, Orru N, et al. Whole genome expression analyses of miRNAs and mRNAs suggest the involvement of miR-320a and miR-155-3p and their targeted genes in Lithium response in Bipolar disorder. Int J Mol Sci. 2019;20(23). https:\/\/doi.org\/10.3390\/ijms20236040.","DOI":"10.3390\/ijms20236040"},{"issue":"3","key":"4286_CR84","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jacc.2014.03.050","volume":"64","author":"G Cui","year":"2014","unstructured":"Cui G, Li Z, Li R, Huang J, Wang H, Zhang L, et al. A functional variant in APOA5\/A4\/C3\/A1 gene cluster contributes to elevated triglycerides and severity of CAD by interfering with microRNA 3201 binding efficiency. J Am Coll Cardiol. 2014;64(3):267\u201377. https:\/\/doi.org\/10.1016\/j.jacc.2014.03.050.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"4286_CR85","first-page":"1271","volume":"35","author":"JA Veit","year":"2015","unstructured":"Veit JA, Scheckenbach K, Schuler PJ, Laban S, Wiggenhauser PS, Thierauf J, et al. MicroRNA expression in differentially metastasizing tumors of the head and neck: adenoid cystic versus squamous cell carcinoma. Anticancer Res. 2015;35(3):1271\u20137.","journal-title":"Anticancer Res"},{"issue":"3","key":"4286_CR86","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4110\/in.2011.11.3.135","volume":"11","author":"TY Ha","year":"2011","unstructured":"Ha TY. MicroRNAs in human diseases: from Cancer to cardiovascular disease. Immune Net. 2011;11(3):135\u201354. https:\/\/doi.org\/10.4110\/in.2011.11.3.135.","journal-title":"Immune Net"},{"key":"4286_CR87","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-62703-748-8_2","volume":"1107","author":"KU Tufekci","year":"2014","unstructured":"Tufekci KU, Meuwissen RL, Genc S. The role of microRNAs in biological processes. Methods Mol Biol. 2014;1107:15\u201331. https:\/\/doi.org\/10.1007\/978-1-62703-748-8_2.","journal-title":"Methods Mol Biol"},{"key":"4286_CR88","unstructured":"Jope RS, Nemeroff CB. Lithium to the rescue. Cerebrum. 2016;2016."},{"issue":"8","key":"4286_CR89","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0166-2236(95)93926-o","volume":"18","author":"JR Atack","year":"1995","unstructured":"Atack JR, Broughton HB, Pollack SJ. Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder. Trends Neurosci. 1995;18(8):343\u20139. https:\/\/doi.org\/10.1016\/0166-2236(95)93926-o.","journal-title":"Trends Neurosci"},{"issue":"4","key":"4286_CR90","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.bbrc.2004.09.199","volume":"324","author":"RS Seelan","year":"2004","unstructured":"Seelan RS, Parthasarathy LK, Parthasarathy RN. Lithium modulation of the human inositol monophosphatase 2 (IMPA2) promoter. Biochem Biophys Res Commun. 2004;324(4):1370\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2004.09.199.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"4286_CR91","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1042\/BJ20070995","volume":"410","author":"AL Giannini","year":"2008","unstructured":"Giannini AL, Gao Y, Bijlmakers MJ. T-cell regulator RNF125\/TRAC-1 belongs to a novel family of ubiquitin ligases with zinc fingers and a ubiquitin-binding domain. The Biochemical journal. 2008;410(1):101\u201311. https:\/\/doi.org\/10.1042\/BJ20070995.","journal-title":"The Biochemical journal"},{"issue":"9","key":"4286_CR92","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.4049\/jimmunol.174.9.5288","volume":"174","author":"H Zhao","year":"2005","unstructured":"Zhao H, Li CC, Pardo J, Chu PC, Liao CX, Huang J, et al. A novel E3 ubiquitin ligase TRAC-1 positively regulates T cell activation. J Immunol. 2005;174(9):5288\u201397. https:\/\/doi.org\/10.4049\/jimmunol.174.9.5288.","journal-title":"J Immunol"},{"issue":"18","key":"4286_CR93","doi-asserted-by":"publisher","first-page":"7500","DOI":"10.1073\/pnas.0611551104","volume":"104","author":"K Arimoto","year":"2007","unstructured":"Arimoto K, Takahashi H, Hishiki T, Konishi H, Fujita T, Shimotohno K. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci U S A. 2007;104(18):7500\u20135. https:\/\/doi.org\/10.1073\/pnas.0611551104.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04286-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-022-04286-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04286-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T23:04:29Z","timestamp":1666911869000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-022-04286-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4286"],"URL":"https:\/\/doi.org\/10.1186\/s12888-022-04286-3","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"assertion":[{"value":"9 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research has been approved by the ethical committee (Comit\u00e9 de Protection des Personnes \u2013 La Piti\u00e9- Salp\u00e9tri\u00e8re Hospital \u2013 Paris \u2013 France) (reference: P111002-IDRCB2008-AO1465\u201350). All participants provided written informed consent prior to inclusion. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"665"}}